Chong Kun Dang Pharmaceutical (XKRX:185750) Short-Term Debt : ₩172,737 Mil (As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Chong Kun Dang Pharmaceutical Short-Term Debt?

Chong Kun Dang Pharmaceutical's Short-Term Debt for the quarter that ended in Mar. 2024 was ₩172,737 Mil.

Chong Kun Dang Pharmaceutical's quarterly Short-Term Debt declined from Sep. 2023 (₩183,142 Mil) to Dec. 2023 (₩181,699 Mil) and declined from Dec. 2023 (₩181,699 Mil) to Mar. 2024 (₩172,737 Mil).

Chong Kun Dang Pharmaceutical's annual Short-Term Debt increased from Dec. 2021 (₩99,337 Mil) to Dec. 2022 (₩123,534 Mil) and increased from Dec. 2022 (₩123,534 Mil) to Dec. 2023 (₩181,699 Mil).

Chong Kun Dang Pharmaceutical Short-Term Debt Historical Data

The historical data trend for Chong Kun Dang Pharmaceutical's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chong Kun Dang Pharmaceutical Short-Term Debt Chart

Chong Kun Dang Pharmaceutical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Debt

Get a 7-Day Free Trial

89,547.33

75,993.41

99,336.83

123,534.14

181,698.93

Chong Kun Dang Pharmaceutical Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Debt	Get a 7-Day Free Trial															134,599.53	104,543.06	183,142.45	181,698.93	172,736.74

Chong Kun Dang Pharmaceutical Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Chong Kun Dang Pharmaceutical Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Chong Kun Dang Pharmaceutical's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Chong Kun Dang Pharmaceutical (XKRX:185750) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chong Kun Dang Pharmaceutical Corp (XKRX:185750) » Definitions » Short-Term Debt

Traded in Other Exchanges

N/A

Address

368 Chungjungro-3Ga, Seodaemun-gu, Seoul, KOR, 120-756

Website

http://chongkundang.en.ec21.com

Chong Kun Dang Pharmaceutical Corp. is a manufacturer of antibiotics. The company manufactures and distributes over 130 ethical, OTC pharmaceuticals and pharmaceutical active ingredients, primarily focusing on the application of its advanced technologies in fermentation and organic synthesis. The product range includes Rifampicin (antituberculosis), DMCT (raw material for Minocycline), Cephalosporins, 7-ACA and other intermediates of Cephalosporins, Cyclosporin A (immunosuppressant) and Lovastatin (antihyperlipidaemic agent).

Chong Kun Dang Pharmaceutical (XKRX:185750) Headlines

No Headlines